Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 152Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Aurobindo Pharma Limited

02 1Cipla Ltd.

03 2Hetero Labs Limited

04 1MYLAN LABORATORIES LIMITED

05 1Vijayasri Organics Private Limited

06 1ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

HPAPI Summit
Not Confirmed
arrow

02

HPAPI Summit
Not Confirmed
arrow

03

HPAPI Summit
Not Confirmed
arrow

04

HPAPI Summit
Not Confirmed
arrow
arrow
HPAPI Summit
Not Confirmed

NEVIRAPINE

NDC Package Code : 53104-7546

Start Marketing Date : 2016-01-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (25kg/25kg)

Marketing Category : BULK INGREDIENT

blank

05

HPAPI Summit
Not Confirmed
arrow
arrow
HPAPI Summit
Not Confirmed

NEVIRAPINE

NDC Package Code : 68554-0044

Start Marketing Date : 1998-09-11

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

06

HPAPI Summit
Not Confirmed
arrow
arrow
HPAPI Summit
Not Confirmed

NEVIRAPINE

NDC Package Code : 68554-0014

Start Marketing Date : 1996-06-21

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

07

HPAPI Summit
Not Confirmed
arrow
arrow
HPAPI Summit
Not Confirmed

NEVIRAPINE

NDC Package Code : 65015-704

Start Marketing Date : 2015-01-30

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

08

HPAPI Summit
Not Confirmed
arrow
arrow
HPAPI Summit
Not Confirmed

NEVIRAPINE

NDC Package Code : 70159-002

Start Marketing Date : 2016-02-02

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

09

HPAPI Summit
Not Confirmed
arrow
arrow
HPAPI Summit
Not Confirmed

NEVIRAPINE

NDC Package Code : 64220-102

Start Marketing Date : 2006-01-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

Looking for 129618-40-2 / Nevirapine API manufacturers, exporters & distributors?

Nevirapine manufacturers, exporters & distributors 1

66

PharmaCompass offers a list of Nevirapine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Nevirapine manufacturer or Nevirapine supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nevirapine manufacturer or Nevirapine supplier.

PharmaCompass also assists you with knowing the Nevirapine API Price utilized in the formulation of products. Nevirapine API Price is not always fixed or binding as the Nevirapine Price is obtained through a variety of data sources. The Nevirapine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Nevirapine

Synonyms

129618-40-2, Viramune, Bi-rg-587, Nevirapine anhydrous, Birg 0587, 11-cyclopropyl-4-methyl-5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one

Cas Number

129618-40-2

Unique Ingredient Identifier (UNII)

99DK7FVK1H

About Nevirapine

A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.

LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS-1 Manufacturers

A LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS-1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS-1, including repackagers and relabelers. The FDA regulates LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS-1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS-1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS-1 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS-1 Suppliers

A LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS-1 supplier is an individual or a company that provides LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS-1 active pharmaceutical ingredient (API) or LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS-1 finished formulations upon request. The LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS-1 suppliers may include LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS-1 API manufacturers, exporters, distributors and traders.

click here to find a list of LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS-1 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS-1 NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS-1 as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS-1 API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS-1 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS-1 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS-1 NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS-1 suppliers with NDC on PharmaCompass.

LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS-1 Manufacturers | Traders | Suppliers

LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS-1 Manufacturers, Traders, Suppliers 1
23

We have 6 companies offering LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS-1

Get in contact with the supplier of your choice:

  1. Aurobindo Pharma Limited
  2. Cipla
  3. Hetero Drugs
  4. Viatris
  5. Vijayasri Organics Limited
  6. Zhejiang Huahai Pharmaceutical
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.